Compare First-Line Meds for Parkinson’s
July 2023
About 100,000 people in Canada live with Parkinson’s disease...and you’ll need to help sort through first-line meds.
Meds don’t slow progression, so it’s often a “wait-and-see” approach...starting if there is an increased risk of falls or when symptoms impair function or quality of life.
Tailor med choice based on age, symptom severity, etc.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive